This PDF is the current document as it appeared on Public Inspection on 10/15/2014 at 08:45 am.
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement (U01).
Date: November 6, 2014.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications and/or proposals.
Place: National Institutes of Health, DEA/NIAID/NIH, Room 3E70B, 5601 Fisher Lane, MSC 9823, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Vasundhara Varthakavi, Ph.D., DVM, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 2217, 6700-B Rockledge Drive, Bethesda, MD 20892-7616, 301-496-2550, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)Start Signature
Dated: October 10, 2014.
Office of Federal Advisory Committee Policy.
[FR Doc. 2014-24606 Filed 10-15-14; 8:45 am]
BILLING CODE 4140-01-P